Showing results (231-240 of 448) with videos related to

Sort By:
Pageof 45
Pediatric Obesity|May 8, 2021
Liraglutide pharmacokinetics and exposure-response in adolescents with obesityKristin C Carlsson Petri, Paula M Hale, Dan Hesse, et al.
The American Journal of Cardiology|September 25, 2017
Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine TreatmentPer Wändell, Axel C Carlsson, Martin J Holzmann, et al.
Atherosclerosis|March 17, 2018
Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern SwedenAxel C Carlsson, Jan-Håkan Jansson, Stefan Söderberg, et al.
Scandinavian Cardiovascular Journal : SCJ|November 27, 2018
The association between circulating endostatin levels and incident myocardial infarctionToralph Ruge, Axel C Carlsson, Jan-Håkan Jansson, et al.
Metabolic Syndrome and Related Disorders|March 17, 2009
Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and womenAxel C Carlsson, Per E Wändell, Mats Halldin, et al.
Scandinavian Cardiovascular Journal : SCJ|July 16, 2014
Effect of cardiovascular drugs on mortality in atrial fibrillation and chronic heart failurePer Wändell, Axel C Carlsson, Jan Sundquist, et al.
The Biochemical Journal|October 24, 2013
Ligand binding and complex formation of galectin-3 is modulated by pH variationsTobias von Mach, Michael C Carlsson, Tamara Straube, et al.
Lipids in Health and Disease|February 25, 2014
The association between "hypertriglyceridemic waist" and sub-clinical atherosclerosis in a multiethnic population: a cross-sectional studyDanijela Gasevic, Axel C Carlsson, Iris A Lesser, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 16, 2020
Use of cardiovascular drugs and risk of incident heart failure in patients with atrial fibrillationPer Wändell, Axel C Carlsson, Xinjun Li, et al.
Pageof 45